Translational Research Institute (Australia)
From Wikipedia, the free encyclopedia
The Translational Research Institute (TRI) is Australia's first translational medical research institute dedicated to translating scientific discoveries into applications for medical practice.[1]
Founder(s) | Professor Ian Frazer AC |
---|---|
Established | October 2013 (2013-10) |
Mission | Medical research |
Focus | Translational |
Chief Executive Officer | Scott Bell |
Faculty | |
Adjunct faculty | Brisbane Diamantina Health Partners |
Staff | 800 |
Location | Kent Street, Woolloongabba , , , |
Coordinates | 27.499101°S 153.031221°E / -27.499101; 153.031221 |
Website | www |
Located in Woolloongabba, in inner-city Brisbane, Queensland, TRI is supported by a grant from the Australian Government ($140 million); and funding from the Queensland Government ($107 million); Queensland University of Technology ($25 million); and The University of Queensland ($10 million)[2] to combine clinical and translational research to advance progress from laboratory discovery to application in patient care.[3][4] TRI is a Pty Ltd. company with four shareholders: Queensland Health,[5] the Queensland University of Technology,[6] The University of Queensland[7] and Mater Medical Research.[8]